<SEC-DOCUMENT>0001077183-26-000031.txt : 20260617
<SEC-HEADER>0001077183-26-000031.hdr.sgml : 20260617
<ACCEPTANCE-DATETIME>20260617060523
ACCESSION NUMBER:		0001077183-26-000031
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260617
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260617
DATE AS OF CHANGE:		20260617

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEOGENOMICS INC
		CENTRAL INDEX KEY:			0001077183
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-TESTING LABORATORIES [8734]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				742897368
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35756
		FILM NUMBER:		261096529

	BUSINESS ADDRESS:	
		STREET 1:		9490 NEOGENOMICS WAY
		CITY:			FORT MYERS
		STATE:			FL
		ZIP:			33912
		BUSINESS PHONE:		2397680600

	MAIL ADDRESS:	
		STREET 1:		9490 NEOGENOMICS WAY
		CITY:			FORT MYERS
		STATE:			FL
		ZIP:			33912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMERICAN COMMUNICATIONS ENTERPRISES INC
		DATE OF NAME CHANGE:	19990120
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>neo-20260617.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ecc0b-6579-70cb-bf4c-377889ac1477,g:34ac94c8-a652-4882-9c62-a79d38496196,d:c247e2b899d64edd9d3ecb444a1d1d88-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>neo-20260617</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001077183</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="neo-20260617.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001077183</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-06-17</xbrli:startDate><xbrli:endDate>2026-06-17</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic247e2b899d64edd9d3ecb444a1d1d88_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:17pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:17pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC 20549</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:242pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:17pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">June&#160;17, 2026</ix:nonNumeric></span></div><div style="text-align:center;text-indent:242pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:23pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">NEOGENOMICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.801%"><tr><td style="width:1.0%"/><td style="width:40.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Nevada</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-35756</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">74-2897368</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.853%"><tr><td style="width:1.0%"/><td style="width:38.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.617%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">9490 NeoGenomics Way,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Fort Myers,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">33912</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">(239)</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">768-0600</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:242pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"/><td style="width:2.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.738%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.957%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.280%"><tr><td style="width:1.0%"/><td style="width:32.903%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.944%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common stock ($0.001 par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">NEO</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;&#160;</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;8.01</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Other Events.</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2026, NeoGenomics, Inc. (the &#8220;Company&#8221;) issued a press release relating to the pricing of its offering of convertible senior notes due 2032 to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;Convertible Notes Offering&#8221;). A copy of the press release relating to the Convertible Notes Offering is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Current Report on Form 8-K, including the exhibit attached hereto, does not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful. </span></div><div style="margin-top:6pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Financial Statements and Exhibits.</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"/><td style="width:6.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(d)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Exhibits.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-convertiblenote.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-convertiblenote.htm">Press release relating to the Pricing of the Convertible Note Offering issued by NeoGenomics, Inc. on June 17, 2026. </a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">104</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt;text-align:center;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:4.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.048%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.273%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">NEOGENOMICS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">June 17, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Alicia C. Olivo</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Alicia C. Olivo</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, General Counsel &amp; Secretary</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991-convertiblenote.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i00194879b7b54f7e9f15b9733449ca60_1"></div><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt;vertical-align:bottom"><div><img alt="image_01.jpg" src="image_01.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:172px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 99.1</font></td></tr></table></div></div><div style="padding-right:20pt"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.824%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORT MYERS, Fla., June 17, 2026&#8212;NeoGenomics, Inc. (NASDAQ&#58; NEO)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a leading provider of oncology diagnostic solutions that enable precision medicine, announced today the pricing of its previously announced private offering of $275 million aggregate principal amount of 0.75% convertible senior notes due 2032 (the &#8220;notes&#8221;) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In addition, NeoGenomics granted the initial purchasers of the notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $41.25 million aggregate principal amount of the notes. The offering is expected to close on June 22, 2026, subject to customary closing conditions. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The notes will be senior, unsecured obligations of NeoGenomics and will bear interest at a rate of 0.75% per year payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2027. The notes will mature on July 1, 2032, unless earlier converted, redeemed or repurchased. Before April 1, 2032, noteholders will have the right to convert their notes in certain circumstances and during specified periods. From and after April 1, 2032, noteholders may convert their notes at any time at their election until the close of business on the second scheduled trading day immediately before the maturity date. NeoGenomics will settle conversions by paying or delivering, as applicable, cash, shares of its common stock, par value $0.001 per share (&#8220;common stock&#8221;), or a combination of cash and shares of its common stock, at NeoGenomics&#8217; election. The initial conversion rate is 70.6140 shares of common stock per $1,000 principal amount of the notes, which represents an initial conversion price of approximately $14.16 per share of NeoGenomics&#8217; common stock. The initial conversion price represents a premium of approximately 35% to the last reported sale price of $10.49 per share of the common stock on The Nasdaq Capital Market on June 16, 2026.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The conversion rate and conversion price will be subject to adjustment upon the occurrence of certain events. The notes will be redeemable, in whole or in part (subject to certain limitations), for cash at NeoGenomics&#8217; option at any time, and from time to time, on or after July 6, 2029 and on or before the 51st scheduled trading day immediately preceding the maturity date, if the last reported sale price per share of NeoGenomics&#8217; common stock equals or exceeds 130% of the conversion price for a specified period of time. The redemption price will be equal to the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, the notes will be redeemable at any time if the aggregate principal amount of the notes that remains outstanding is less than 15% of the aggregate principal amount of the notes initially issued in the offering and certain other conditions are satisfied.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the pricing of the notes, NeoGenomics entered into privately negotiated capped call transactions with certain financial institutions (the &#8220;option counterparties&#8221;). The capped call transactions are expected generally to reduce potential dilution to NeoGenomics&#8217; common stock upon conversion of any notes and&#47;or offset any potential cash payments </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NeoGenomics is required to make in excess of the principal amount of converted notes, as the case may be, with such reduction and&#47;or offset subject to a cap. The cap price of the capped call transactions will initially be $20.98 per share of NeoGenomics&#8217; common stock, which represents a premium of 100% to the last reported sale price of $10.49 per share of the common stock on The Nasdaq Capital Market on June 16, 2026.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NeoGenomics has been advised that, in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates expect to purchase shares of NeoGenomics&#8217; common stock and&#47;or enter into various derivative transactions with respect to NeoGenomics&#8217; common stock concurrently with or shortly after the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of NeoGenomics&#8217; common stock or the notes at that time. In addition, the option counterparties and&#47;or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to NeoGenomics&#8217; common stock and&#47;or purchasing or selling NeoGenomics&#8217; common stock or other securities of NeoGenomics in secondary market transactions from time to time prior to the maturity of the notes (and are likely to do so during any observation period related to a conversion of notes or following certain repurchases or redemptions of the notes). This activity could cause or avoid an increase or a decrease in the market price of NeoGenomics&#8217; common stock or the notes, which could affect the ability of holders to convert the notes and, to the extent the activity occurs following conversion or during any observation period related to a conversion of notes, it could affect the amount and value of the consideration that holders will receive upon conversion of such notes. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NeoGenomics estimates that the net proceeds from the offering of the notes will be approximately $266.15 million (or approximately $306.16 million if the initial purchasers exercise their option to purchase additional notes in full), after deducting the initial purchasers&#8217; discounts and estimated offering expenses payable by NeoGenomics. NeoGenomics intends to use approximately $25 million of the net proceeds from the offering to pay the cost of the capped call transactions. If the initial purchasers exercise their option to purchase additional notes, NeoGenomics expects to use a portion of the net proceeds from the sale of the additional notes to enter into additional capped call transactions. In addition, NeoGenomics intends to use a portion of the net proceeds from the offering, together with cash on hand, to repurchase for cash $276 million aggregate principal amount of NeoGenomics&#8217; 0.25% convertible senior notes due 2028 (the &#8220;existing notes&#8221;) through privately negotiated transactions entered into concurrently with the pricing of the notes effected through one or more of the initial purchasers or their affiliates as our agents, and the remaining net proceeds from the offering, if any, together with cash on hand, to repurchase up to an aggregate of $25 million of our outstanding shares of common stock from certain purchasers of notes in privately negotiated transactions, effected through one or more of the initial purchasers or their respective affiliates as our agent, entered into concurrently with the closing of this offering, and the remainder of the net proceeds, if any, for general corporate purposes.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The concurrent repurchases of the existing notes and shares of the Company&#8217;s common stock described above may result in the Company&#8217;s common stock trading at prices that are higher than would be the case in the absence of these repurchases, which may result in a higher initial conversion price for the notes to be offered.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Concurrently with the pricing of the notes, NeoGenomics entered into privately negotiated transactions (the &#8220;note repurchase transactions&#8221;) with certain holders of the existing notes to </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">repurchase for cash $276 million aggregate principal amount of the existing notes for a total repurchase cost (including accrued and unpaid interest) of approximately $263.19 million.  The terms of the note repurchase transactions were individually negotiated with certain holders of the existing notes and depended on a variety of factors, including the market price of NeoGenomics&#8217; common stock and the trading price of the existing notes. This press release is not an offer to repurchase the existing notes, and the offering of the notes is not contingent upon the repurchase of the existing notes.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the note repurchase transactions, NeoGenomics expects that holders of the existing notes who have agreed to have their existing notes repurchased and who have hedged their equity price risk with respect to such existing notes (the &#8220;hedged holders&#8221;) will unwind all or part of their hedge positions by buying NeoGenomics&#8217; common stock and&#47;or entering into or unwinding various derivative transactions with respect to NeoGenomics&#8217; common stock. The amount of NeoGenomics&#8217; common stock to be purchased by the hedged holders or the notional number of shares of NeoGenomics&#8217; common stock underlying such derivative transactions may be substantial in relation to the historic average daily trading volume of NeoGenomics&#8217; common stock. This activity by the hedged holders could increase (or reduce the size of any decrease in) the market price of NeoGenomics&#8217; common stock, including concurrently with the pricing of the notes, resulting in a higher effective conversion price of the notes. NeoGenomics cannot predict the magnitude of such market activity or the overall effect it will have on the price of the notes or NeoGenomics&#8217; common stock and the corresponding effect on the initial conversion price of the notes.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The notes were offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act. The offer and sale of the notes and any shares of common stock issuable upon conversion of the notes have not been, and will not be, registered under the Securities Act or any other securities laws, and the notes and any such shares cannot be offered or sold absent registration or except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any other applicable securities laws. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release does not constitute an offer to sell, or the solicitation of an offer to buy, the notes or any shares of common stock issuable upon conversion of the notes, nor will there be any sale of the notes or any such shares, in any state or other jurisdiction in which such offer, sale or solicitation would be unlawful. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About NeoGenomics</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. Headquartered in Fort Myers, FL, NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories for full-service sample processing and analysis services throughout the U.S. and a CAP-accredited full-service sample-processing laboratory in Cambridge, United Kingdom.</font></div><div style="margin-top:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward Looking Statements </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;project,&#8221; &#8220;guidance,&#8221; &#8220;potential&#8221; and other words of similar meaning, although not all forward-looking statements include these words. These forward-looking statements, which include those concerning whether NeoGenomics will issue the notes&#59; whether the note repurchase transactions will settle&#59; whether the common stock repurchase transactions will settle&#59; the anticipated use of the net proceeds from the offering&#59; expectations regarding the effect of the capped call transactions&#59; expectations regarding actions of the hedged holders, the option counterparties and their respective affiliates&#59; and whether the capped call transactions will become effective, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Each forward-looking statement contained in this press release is subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Applicable risks and uncertainties include, among others, risks with respect to the market acceptance of the Company&#8217;s products and services, as well as the risks identified under the heading &#8220;Risk Factors&#8221; contained in the Company&#8217;s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and the Company&#8217;s other filings with the Securities and Exchange Commission (SEC).</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We caution investors not to place undue reliance on the forward-looking statements contained in this press release. You are encouraged to read our filings with the SEC, available at www.sec.gov and in the &#8220;Investors&#8221; section of our website at ir.neogenomics.com, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document (unless another date is indicated), and we undertake no obligation to update or revise any of these statements. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Investor Contact</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>InvestorRelations&#64;neogenomics.com </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Media Contact</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Andrea Sampson<br>asampson&#64;sampsonprgroup.com</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>neo-20260617.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ecc0b-6579-70cb-bf4c-377889ac1477,g:34ac94c8-a652-4882-9c62-a79d38496196-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:neo="http://neogenomics.com/20260617" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://neogenomics.com/20260617">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="neo-20260617_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="neo-20260617_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://neogenomics.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>neo-20260617_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ecc0b-6579-70cb-bf4c-377889ac1477,g:34ac94c8-a652-4882-9c62-a79d38496196-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019ecc0b-6579-7549-95a6-88b8d559109b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019ecc0b-6579-73c9-baca-9e5e8c14ba80_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019ecc0b-6579-76ee-8e1a-e9b2a4ec700d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019ecc0b-6579-7b61-a4f4-632d81c70966_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019ecc0b-6579-7bd2-99cb-e14e9f2f46ce_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_019ecc0b-6579-7ba3-8da4-d1a3833f9a21_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019ecc0b-6579-7d58-9b6a-ef68f531a669_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019ecc0b-6579-79d9-bbe7-c07e51307760_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_019ecc0b-6579-7c89-87e2-b427b8310926_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019ecc0b-6579-7dd2-8b97-8e868e335522_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_019ecc0b-6579-716c-b802-8d51fa701a10_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_019ecc0b-6579-7db2-850e-ece29784854d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019ecc0b-6579-7938-b02d-9ba51a6d37c5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019ecc0b-6579-75c8-ae53-9a8546dfe88c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019ecc0b-6579-7357-9e41-a82a8df2d128_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019ecc0b-6579-7747-beb6-d956b5da4f3f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019ecc0b-6579-7b1d-bbd9-69f096421ae5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019ecc0b-6579-712a-963a-5164be880b99_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019ecc0b-6579-7b55-bbfc-f5349873b09d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019ecc0b-6579-7793-9743-4cf73e5fc084_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_019ecc0b-6579-74fc-8667-4e02932906b1_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019ecc0b-6579-74f9-9d1b-8baebed119bc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019ecc0b-6579-7778-bc16-07a2964559ac_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>neo-20260617_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ecc0b-6579-70cb-bf4c-377889ac1477,g:34ac94c8-a652-4882-9c62-a79d38496196-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://neogenomics.com/role/Cover" xlink:type="simple" xlink:href="neo-20260617.xsd#Cover"/>
  <link:presentationLink xlink:role="http://neogenomics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019ecc0b-6579-7786-b779-9f030974d1d7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_DocumentType_019ecc0b-6579-7786-b779-9f030974d1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019ecc0b-6579-7df6-a413-4b7975636bb0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_DocumentPeriodEndDate_019ecc0b-6579-7df6-a413-4b7975636bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019ecc0b-6579-7870-b0cf-8768388b9f46" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityRegistrantName_019ecc0b-6579-7870-b0cf-8768388b9f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019ecc0b-6579-78ef-92c8-8e1316fe55ba" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityCentralIndexKey_019ecc0b-6579-78ef-92c8-8e1316fe55ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019ecc0b-6579-78dc-8f64-4d22e662f981" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_AmendmentFlag_019ecc0b-6579-78dc-8f64-4d22e662f981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019ecc0b-6579-7b5f-bad4-c5363a0e4528" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019ecc0b-6579-7b5f-bad4-c5363a0e4528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019ecc0b-6579-7895-b373-dac26bd3e395" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityFileNumber_019ecc0b-6579-7895-b373-dac26bd3e395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019ecc0b-6579-7b20-be1d-427c4767ca8a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityTaxIdentificationNumber_019ecc0b-6579-7b20-be1d-427c4767ca8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019ecc0b-6579-7751-b2cc-b7cc95ebd86e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityAddressAddressLine1_019ecc0b-6579-7751-b2cc-b7cc95ebd86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_019ecc0b-6579-7d23-8149-bbdcbc0cf1de" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityAddressAddressLine2_019ecc0b-6579-7d23-8149-bbdcbc0cf1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019ecc0b-6579-7111-9182-86d9fe21bb14" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityAddressCityOrTown_019ecc0b-6579-7111-9182-86d9fe21bb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019ecc0b-6579-7067-845a-6c6feba28d6d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityAddressStateOrProvince_019ecc0b-6579-7067-845a-6c6feba28d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019ecc0b-6579-77de-a45b-a997483c0e51" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityAddressPostalZipCode_019ecc0b-6579-77de-a45b-a997483c0e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019ecc0b-6579-7a7d-96a9-cdcfa55c0908" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_CityAreaCode_019ecc0b-6579-7a7d-96a9-cdcfa55c0908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019ecc0b-6579-7cd7-a2f5-423474e6402f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_LocalPhoneNumber_019ecc0b-6579-7cd7-a2f5-423474e6402f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019ecc0b-6579-71c3-aa41-1e62a1d5eb3b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_WrittenCommunications_019ecc0b-6579-71c3-aa41-1e62a1d5eb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019ecc0b-6579-7216-81db-cc171432ac2f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_SolicitingMaterial_019ecc0b-6579-7216-81db-cc171432ac2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019ecc0b-6579-7ac1-8168-8917529cfe64" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_PreCommencementTenderOffer_019ecc0b-6579-7ac1-8168-8917529cfe64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019ecc0b-6579-7817-ae47-aa1241d27a23" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019ecc0b-6579-7817-ae47-aa1241d27a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019ecc0b-6579-7116-9df6-95fd157bb8b6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_Security12bTitle_019ecc0b-6579-7116-9df6-95fd157bb8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019ecc0b-6579-7c58-b76a-f60408554f21" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_TradingSymbol_019ecc0b-6579-7c58-b76a-f60408554f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019ecc0b-6579-7a8f-9863-4110facf577b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_SecurityExchangeName_019ecc0b-6579-7a8f-9863-4110facf577b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019ecc0b-6579-71df-b4ab-3ddf2fcca909" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ecc0b-6579-760e-be90-dfad789c1a2d" xlink:to="loc_dei_EntityEmergingGrowthCompany_019ecc0b-6579-71df-b4ab-3ddf2fcca909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_01.jpg
<TEXT>
begin 644 image_01.jpg
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MAAM-A28E$DSN229.S0S[$D72;,5IWX?T@E>Y#80+,7JF!GP*;V"1QT=@=80
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M1SYYR\?Q]CK]QG'PMP>UMCW4OZ$MM() \*!; 'I/ZZCLJ0MO21-H?JHDP^H
MBG(,P&<1SC6S[BR@Z0+@$_ )^(2*!#P3WZ$X?->7:YIN[J'\[BX6?O0X.-IC
MFKEQA*+Q9I%S^S2?>HG-0*\8[P)HJN)6 L'];@'HTI;QF1%7UF4.U6NKQHWH
M6 7X+&+;R=1-*+\%? (^ 9^0WZ7ST0&=_\V/?0P"FM'&(L;9J.;QL":WEY9H
M9I58)ZQ1-_[KI+R556TX 8[VH)J>G=@GE@S=1"#8X1: WM!\CKC_N8< I09=
MSP"?Q7[ZJ6CF@U:G.@CP"?@$?$+^E)H83.#9XL/[=^\QE5^/TTZ)%(T/L[HL
M^V\TBZBLK,<=8X_JK.57#ZI9K?YZY1,GNC*&I3X9RMVP[IQXM#:*$T_ )TSC
M^YG.+T+Y+> 3\ GXA'R9[/>E9/\.D1S[:-W*T/?F:6MT"M8NJ93_<'_>:GJE
MQJ=VKV%^VA#!- &/AEV :<;E?:*;.J8NO3+K%H"2[8VU!2^ /P"?,*L$_9^T
M&%0@< "?@$_ )^2SG$OGEXE-1C]MF"J:L8*2_*'PK^2Q&=X84C3^@)@XX:>[
MQV+<#/SK)57%QU""\KYP4)_HYCP!:&;5]I%N >C.NK;AH^$4P">,Y\0"@,9;
M@$_ )^ 3\I'"\4D^ZVS[!@L;T[!6^4A=,V?GDF\_\%&<_HM^4Q#.]8*B\;*
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M2.>GB.^VY. I2A1/A3.AS^5T*G]!<@#]!\:O.""1;!_)#MPW+X_E%F^>Y#2
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MS@5\V@*?0N%'0Z*UO 0?RYUL9@O*;P&?@$_ )^2-G*N,8BHE[=TWS9PK^A_
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M4IUG]0\C3BS.=[.2[/B5=/A9[;N?:6,)=C\!G]KA,P>@<WF4CKB-%,^]X8R
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MEAK:CP!QW<<ELGK&KJ2,72NVC!R!R 9\:H=/59YNN4M4=VC?=S\TY:]]!22
M3\ GX!/RLVA])Z#;R*8KIY6HAM$@9FRCIG>T,XFQEP)VA"F[Z_F$YN'V>VGA
M\F142>TF8P)!XB&MNY^9\,,X^PGXU Z?%^!C*X.%\X0PDU$X)> 3\ GXA*Y
MD1=',RH+W"HJ&_O#:! _OI&KF,381Y1#C0W2U[<R>NB_:7RAIPD2YGAY)BR6
M-A[7//NS5>VR(K !G]KA4ZG:_6K(E,<9+)[[O?K(!/@$? (^(>:_7_.9),6=
MV/6$V(J CGRXC</\7&'+QP+S54#-ZE/MLS6>$]@H9KTPP,NGBC67#R! W*ZU
M^5#&0'(!^/0&/J-.<9$IEW,X&T3W^;PZ:P'G!'P"/B'H,IK6W"=DRLU,X'.7
MFC\-HT$L%75ZL]G]M!,[@A%K4>=F>N"=&E_DAZII2D\\6BQ=-I4@\;1& 'V-
M(+</(AOPJ1T^E2K7#J7__RT&"^A)83F5<$[ )^ 3@B[GLR^JW9AC3'9C'H+!
M(-[QYDQF$F\GZ%XG%;Y!JMU9&L]ZGE.[-3TUNZ9^Q\226+ITO4;X/%6WN?0^
M1#7@TQ/XS#UOA1I(S&(67-09 @<%? (^(>A2/BN_K;G/1KZNW5C+(?:*.C<R
M:>[5562YRPI[=%W4Z1NRM38R>5N=)^W)1XQEC"\0)'Z@$4#7UCCC>B.R 9^>
MP"?%+/W_SS$HOSU'"^A3V6Z]$. 3\ E!%S2EI5?(E"TLQC]8[I*>VD" H#S_
M3JBQ1F<8Q-UV4;%F4,':H5>U.U4U ]*W:"7F]S2]JWF<\71XF<;1*T<5X"*J
M 9^>P&<.0,N9#"5O%Y&&:7!2P"?@$X+^2U7.>'4DB<%<ST.8WPP5C*8U#PC9
M\@T&N=.QPBV]50U,K,0ZK0?4?=*6NZZE=!A!XFY]NY^E/\'8%<"G9_"I9,MO
M:/QPE-_V_%;B%C@JX!/P"4'G_35;<NOWV<VJ>=QO S9W$"K\V/LN@W+W7-?;
M@JPXR+4>UC5?Z@R]N(A?'C6[^YDRYA$HGM$$H.^LS(P*(ZH!GY[!I^K>9LKU
M#."SH\B6/T+Y+> 3\ E!(M?EUG)=!FOW*5'M3H?!H ++&0WR[?<85!VD??4;
MFS\#N$NTG1NS99/?6@4_U3)\L,;1*UVQ5/@11#7@TS/XO/ !Z9\L!B?;$J7I
M@$_ )P15;;A5\USU?%VMA9G\0H%6MNI3KF80?X=%I*&TL%Y^I&$@/=A>;8FF
MF;S'CX\=3X=G$RAVZ #0VK2QK3XSZB9$-N#3,_A4YZEMN8!#^19=VU2W.3@L
MX!/P"05:$7>:WWZS+EGV9R46PEA0(:K8=*>KJBR_YTV4W]U?6&\^=UZL4],9
M@;5^'9"JNM(2*+9HVOT\&<^4WHNP!GQZ!Y^DRL;^(<O=P@ ^.\E6WT?71, G
MX!,*K&C]H]^''S.I5AD#@T$%*=5X2-\&7'[/7!?,R!5*&$*F3.DIMTU\**K=
MN_S\^+'TR,FZSG[6IL.K'$?@;!O@<ZFG[\"67Z2_^R\6G1.MQ 0X+> 3\ D%
M4FJ\G25?8;!6;U3C8& PJ##5'5*CX!A\!#I8.*7ON63]J)[!J/*7?F\L$FLN
M[T.@F-0!G[&T<>39+2-'(+ !GQXG-,4$H(OH;Y_U>RD77;_S2Q=LP"?@$_ )
M>:K*QN$4.T=\/]O33#X,8T$%+=/Y"H.9GQTBXMQ9"%_=U'B5I7H:#26.B.B&
M\1Q>0VQ3^&Z"Q78MY;>9\'Q$->#3^Z1F[5"*P5<9?,D[ZX?YOX!/P"?@$_+>
M3Y/W:6OTF+_K:.$U.H&@B_3@ZG[DZ]L9G/M\M!#@<P@]S%_U)-PRSF6<0GW3
M\!OB&:-)"WQN-EJ=-\=A+A;@LZ<2FW8& 'H @\L!GX!/*&CB4>KGOHR26ZCP
MU1VB_'$Q@WAT^7^L-]TJ+<-5U5E/,_D93J\BEBZ;FFT2E'\ /5V;"M^#P 9\
M>B[5S,*4RQG 9W>1G7#$G%6?@@,#/@&?4%!$?O%GW^^T6.X\6 H*A$QG$OE\
MFZ]CTI1OBHHU@_B^Y"DMO8B@&_4DDO(7W,B\?L?$$@+%A):9GVGCN9H:@:Z>
M@$_OE1NCM)L!@'8(,SD3#@SX!'Q"@5!N;6[W>:)[G.YS-(P%!4(SF@:3W[_N
M\URIC7*E._B^Y*A3KBE);^,Z0'YE.OPU@L7C&@!TS\K,J# B&_#9([*ES:3\
M]A](= "?@$\H$(HF)S.8+9A!10H4G)ATBHML6>OS<]@=E-/-YIRD+]3Q@K,=
M;N?6EW!\)=FSGVECHX[2V[J4,0N1#?CLH06U+\7E*@;PV47OZC=B3@N2'< G
MX!,J]-^J^0R:FSR&9G!0H&2Z4?+]TSZ?][D\OW'Y'P   /__[)U_<%35%<??
M;L*O\J.6(B F^Y8?I8Z4J1J!5D<F5J>*2+)O7])6 A4[4SN,2CN5.FUGL$L+
M3D<HR.Y2F^G46(N6OG=W2:HBNTNZ2%&FFA:F+12T,\H4^6%' Y0?!4*VYR:U
M)-H(3>_RSGW[_<Z<?W?>GG?N?>?SWKGG&,:ET8*FP8%HZN5 5!046[M1Y]Y@
M:*RU.3.:R)JGR0I*+1=:'W.F##2@XBJ:^@S%X8DBQ':_+1A-+??<+S7.)+J6
M-SCYI0_[!]W#.L,H!!#,?6CNTQ\C/^WD==]2OS/F//L1-CZRW"BWV"Z+.G,1
MO-!["EKB2>9[\3':BV_&G8)*2I$-$P-1]RW6:],2FXWJ?+F&SG6FRR1/L4,Z
MZ8:YK!*0?J@I'QY,L+A#.7QFS4/QULJ)6-F 3P]],Y^NYQ1[ +7%'XUZYTH$
M,^ 3\ GY4O,S0RDF7F*^%^^F9\85N%E02:G>*:/GV1;F:_--NL[+-?-L(1"T
MQ+)N6%3JC..&+>;X(?82V= \@L5.U0 :SX06864#/CT3P4$P*M878>VKMDZZ
MSA_3YHI* < GX!/R8X(;HI@XP'D?#MHIQYBU<1!N%E1J(D9:JD&%V#2]O%K3
M,CQ@BQU%<,9+\K?]$'@K,F.&$BSN4E]Z&]ZZZN6*(5C:@$\/DYZI=$T'-2B_
M/4'WL@8!#?@$?$*^D^5\5KZP9[S_=M#^^R!N%%2:ZS/].5H#9SGG2$9$S-,M
M.9]9A.2\P[#%W7Z)NT+!",2SYH,$C.=4PF<R9QY;G0U?@Y4-^/0PN@/DHV]H
M\/53VA\T+"T!? (^ 9_0A>+SR\R3VQ,R <>-@DI2#>M&T!IXFW5E0M1=J95/
MZ8)7%\$1KU&2.,Q/L;<F6_$) L9]BK]^=B9RXQ=C90,^/15!@CRPK@%\=LHC
M @AJP"?@$_*3-"CKVT\YW5C<*:@D%2L$:0WDF*_1Y_5I.E33,H8N^"_*/__:
MXMN^B[U\=7D\:R:5G_W,A;<VMAD#L+H!GYZJ5LS@_F:OQ]F&F0ALP"?@$_)'
M<A$+RN:,S+MI;D7'<:BD7Q!%W4>8YT8[C7IGI"Z)^6RZX)-J'> >,NS4!#\&
M7R(;NI& \8CBKY_'DYNOG(RE#?CT5-7Y<MI<8]S/-?SG/+F5'HW@!GP"/B'M
M5>\,#-BI-N8E?8_@1D$E+5M$>!]/TH6]ZIVRH"4>5>U,2JQ_+G_;C[$7WSAI
M4")CYHHP\_,!K&S I_<)>GHT7=\K&L#G6;JOW]-SKA7@$_ )^(1ZJ*9E',7#
M/L[''6B_M7"CH!*'SRERUBWSJK ;=8#/D72QKRK^\_\LM\5M?HZ_^.90'0'C
M&<4 VAJ+&4&L;L"GYZIS;Z%K;-< 0 _2PV & ASP"?B$-$]JKV6>U)XQ(AO"
MN%%02:N;F5YGO$Y/E]GB+OZ.[#[C=4)YPM&P;H2?XV_5IHJ111B[TA[?6#D1
MJQOPZ;ED^:TE?J1)]]N<',X.^ 1\ CXAC>'S#N;[[=^,!4V#<:.@$H?/@8&H
MF^4]#SWU$/^SV='4=]279KA?\WO\R;$KB9RY3'77VW@FM BK&_#)9),=&[#$
M'AVZWQ)4H%LTX%-/^+3<!MEL!N:A<4C4;+&0^3[[&[\>I8*@BQ;M%\&H2# _
MFQWG?1R)-A*ZT.V*__@;]+NA4HC!1*YB*@'C4<4 ^GQC6Q6ZW@(^F23K:9FL
MG]8 0 \;M<Y4P"?@4S?X#-AB!]E&F'=&X/>PU\E:T$H_RCNA3:U%(@%!\CDB
M[F/>="AMS-HXB*\#[=0$NM .Q9][?VI4-98$/#F.45:$QD/[XJTHO05\,M&]
MC0."EOB9!O ID_AF5J #^ 1\PK0PVN-^X2U\%@+!J%C/V4?T#$5#1 CJ8B=Q
MFSP#S7H2 .M<R!9?5_R'C]/#_<Y2BL%$+GR/8O@\E<R%OH#5#?ADH\B&B72]
M>S5((D_3_G-/R<ZA WP"/F']VXMM=XVG):4+F@8S'U[?*<^D(I& H"YVNHI;
M/OD^VTW/W5$\G=<]T/@%U>5#AI7^>"G%X-I\>"P!XP&5 !K/FLE8WL#X", G
MF[W"L,17U<\"+HJ]*5NA SX!GX!/V/]P1BK6??;3LQ=\EQ5AZH#:\0T1IPJ)
M! 09<BS2&-YCD=RW^':FCJ8J9/<RQ26WRTLM!N5HE$3&7*MVWJ?Y>]E-%RL<
M\,E&\Y\:2AO:<SHT'PI&Q=-&O3.DT+&X /@$? (^8>Q+2KN3V=<8^^B \26,
M68&@+M4[PUC/0K?$4;K&JWDZK\ZME?,XE9:\U3:79,./9&;\3(+&DPH!]/AC
M+U1.PPH'?#+;<*^6;]0T2"9/TOV>6W+EMX!/P">L/];17:[OZ=XZGM;*WQDG
MLWOH&C^*1 *"C.[*45L\R[I,/N),9^FX(LSPVU:J9ZT:\^-&$3"^JO;K9PB'
M^P&?'/WX@.(F9<6RUXW:YDK )^ 3\ F[X(MS6WC;9\%*?YJNHYVOCU(O8L8G
M!)V7[/[,NIHCXL[BY[6:EN$2%M66K?A_MF??+&\$DUESN9S3J0H^D]GPKV/Y
M:IS[!'SRTOR,++]MU:2#Y9,E-9<.\ GXA/6S46+Z=B_#LKS.K9;G*AGOI;^2
MG<^12$#0>SFE^Q!K^+3$W?R<5BO+Y\3;ZAH-I=XU:IQ)I1R':S:9-RN>^?GN
MXYF)H['" 9_L5.?>)->\%N6W$1$!? (^ 9^P#[%CM*?=XF58ED53L^DZ3O'M
M!BR2GC9D@B!NLMP&YO"YB)_3;'$77=PYA9V5GBOUDHS5^?!E!(P[%<)G9R)C
MSL(*!WRR4[U3%K3$,DUF?^Z@>W\%X!/P"?B$]?GR/)KRM,<"P><7.<\-I/U^
M*9((".K)4:E;%1]=5-Q$S5W"S&-RF''J":6']>W4O24[6Z^'"!97J#SWF<R:
M*['" 9\L-;L+=+9ID%QV!FVQPML!\H!/P">,L;U#SX?K/(5/RJ$8)[)R#[T/
M200$]5#$F2Y+]AF_,'J,8X+R9X5_\C#?EKZ75FLRY@T$C:<4 NAVG/L$?+*5
ME;Y=)FY:E-59[IV^?T$&^ 1\POI3N76(<AA/CPT1W-W/N1MPF>4V((F H%[Y
MSZ<XYS^47_Z$6Q)^G=IA\6ZKG &(2#2,QK:J 8I+;P\G6\>;\"S@DZ7JG8'!
MJ!M76\)?1 BJ>68,X!/P"=B"?0 ^[=0$[X)25J.Y2UB/HK'%'"01$-0K_YDD
MY]\R7K>"E\-LL5!E>0?]WK<0A>>5R)C+%,+GV359\PYX%?#)5K7-E?1?]NHP
MRX_\_7U?=[\%? (^8?VQ W+.IF<Q*4??V6(I8_^<I>?G3"01$-0KIZR@M?$F
MXWX7S7R<59TOE^,'%/[!(P2?UR(*SRN^J?(F@L8.54V'DCGS!_ JX).Y;VMD
M@J)!DGG$B#A5@$_ )PS6P_8:-;\<Y^$7E#)Y+IVQ?\Y0GG<]D@@(ZK5N+Y?S
MQ-FN6TOD^3BK8=T(NJ@_*4PL?BM+[Q"%Y_7OKK=[E7W]S)BYF#,%/@9\\I5\
MJ14539P[O_6"(;\>$P!\ CYA_4G2]GC:$;L+/MW'&?OH-,'G54@B(*B'9A%/
M66(7XW7["A]GU39/53B?KY,VI(?1Y;:W"@4C0-#XA,+2V_V8]PGXU. MX"?I
M/_U5@V3S',7"$E]VOP5\ CYA@$_ )P1=&OA4V[S5Q_#9/4M*U=>)XT:=6XT(
M_* 2.7.NPM+;D[*4%UX%?+*6'$#>/2[@C 8)YWY*IF8 /@&?,!C@\X+6[FU#
M)@ABJ/E/#:6UL1WP>1$*VF*5T@W;2N.+W'^#SXPYGJ#Q'65?/W/F8G@5\,E>
M!!F!J)O6H/R6KL]MH:1O&. 3\ D#? (^+SA.+X0D H+>E^_8XD7 YT5L<)0(
M;%$XP/097W>._#_4E \/)FC<HJ[T-MPBRWGA6< G>]5ON$9^6=0@Z3QKV.)^
M7QT; 'P"/F& 3\ G! $^[50;#T=]ONL3<;O"$2M?0?3UK7C6_*["<Y][5^8G
MCX)7 9_LU55^*[ZI2??;@W)0-. 3\ D#? (^ 9\0Y!OXM,0N+LGW-(7E<"<I
M:9N,Z.M;B6SE]02-IQ3!Y]%XSL1(&\"G'JII&4[_;YL6B:><A57O# %\ CYA
M@$_ )^ 3@GP!GVS*;FVQ4.&?VHV2VP]78W[<*(+&78K@\TPB&YH'KP(^-?*W
M?-EU1(/D4\ZP\\?: GP"/F& 3\ G! $^N<"G/*.I,&E>B\B[ 'RV50U(YLQU
MBN"S,YX-_Q#G/@&?VB@6"P:C;DR.-KEXG_P+  #__^R=>W!45QW'S]Z0\BQ2
MREN:NY *"D4ML5B<48LHF")A[[T),X HC@K8.IV*K\[4L<$'MITIR&Y"S$Q'
M' A@]YZ[(:72[&YI.G5$91B@BK0PE+8RT JBO$IYA*R_LZ%.F(Z6)"<YY^S]
M?F;.OSMW?^=Q?Y]SSX/G(BY748ZPV)8H,YV%FVZA_[)/40S_1PG^S.9N&Z!-
MC!S?U2L^*,J+PU]A;C!:69NL2A99GE^G<8S.LEAC*0, =.RW@ZAO[-*XW^Y2
M'Z1[6OK0@[PLZT_1"_Q+:'GO3TW&OC^1L5NIY+I?HDVK=X[MCZAV$3>XF]KN
MVSH-#I8;_+S !^=10CX,2$#;+)=O8DO6]X-\0CY1()^0S^O*)>;Q#R.) * #
MY0V#:>SX&^3S_Q%K+*4'^:>4/^0%_V(56\:@Y;T_Z[+1NTD<3\N13_M 7;IT
M!*(*^32'7(3B/H<&Z#,&)*'G*,%:D']FR"?D$P7RV9ORZ?)UD$\ ()]2W[W*
MJ?1GTL.\(^D/O4"#);[ W0!"%DD:]TN2SU.UF>C'$57(IU'<T]*'_F<M_=^K
M!B2B^UFL,0KYA'RBA*H<I?>#K:Q-5E=;ENNOTC@^ERGGFX8D H".[Y+4".H;
MA[7MMQ[?KD/B_2 ]3*N4A-GAJ\5,'5K>C;Q3F$72&$B2S]9XNF0NH@KY-(Z*
MIC'T?U\R9/EM@BVM+X9\0CY1PE+\MY@7C%<JGQY?J7&,KE#.]UDD$0!<EU..
MI;[QNL;RN55QA'(12JCJ16(E91!R@X5H=3=.3:;DAR2.;3($5/Q6+L<BB"KD
MTRQR$5;I5\E;?=&CY0+SN)F3/)!/R">*>?(I<C2//Z1QC%J+''\>D@@ .N#Q
M#U'?>%/7?FLY?+/: "W>,) &UXRD1.(D)?%3T>HZ)9\S21PO2Y'/K-T@OJ8B
MJI!/X\@?>N;[AB2D?V5.ZE;()^03)13EE.J\AMX%]VD<GZLDGXN01 #0\5V2
MND.,'=K*I\O7J4ZZ1].#')+TA_91(C$,K>[&6=T\=BB)XQE)2V_W5"<GWX2H
M0CZ-I/W@LZ-F++\-5AFWO0#R"?E$Z=HABA[_A,IF27+W-8WWQ;=9'G\ 200
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M_G(CEM^ZR<7:G7X+^81\ I/?49_1>RD?/X*/$"#TB/W9+O^=QOVTE9QMN;H
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MR#-5)]JC)9V8]IH0630\>:QY-AJ-9^R3W9;/M'U8W!N*B$(^0X,7C*>X'39
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M;<R FJS]O 3Y;%V;+BE#1"&?H<-)33!@6=J[$WA-),S](9^03\@GN,9_
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M2[5\^<Q&DFA-R"<@6G==;)YXG>&RY--5V18=\@GY!,%BR>B8_BN+)05&'/4
M@ ;B;ITJ)V>03SPS(3OIETO(]CP--_6*B+E-B,(JR&<VT@+YA'Q"/K6_J6PU
MK8_/^*7 D1NUE\I /B&?('#0<R+)HJ+#]I?CZR<(!#'W0Q33KQM?<FO)[6I'
MWJ#)YR'(9W5(9QL7D3P.:UCSV5$L"DSVD$]0>EMY'DG=%B;EMX=$F_<)R"?D
M$_()WCYF,Q]7<F?^G.8]JLY?1H<!UJ@S=DM+%TW/(X8IKUUE5-MIDL\^+"*O
M#LE\]#J2QP$-:SZW)7K%)+0HY!,<[^>(*FME47YK^T]H/2,/\@GY!,%#E=Y:
M\L\,YK1^T>;-1X<!UCCR4HKEOS$8;R]0_C##,/F4O]!P8\_3C<U%).HGG8U^
M6(=\IG+1[9W[F^K1HI!/\%^*(76>)IOR6]M+:-O]%O()^02!G-,T;2(Y,66
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MCKR<T?%1)U[]-#9O.>UR @#&2IOWL9#M_9/A./B'L#+3^39\W)UQPN+S_P
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MN*EN. G9+$\+DF6G$SB^)P$^7UZ4KA@$CP(^(>FY,H7B<U"1"6LEC??] )^
M3PC*CE^EA3<.Y&QOBKF:L8P/@80ZK9KE933G/*YH[J=9J'ZPZO Y2!+Y-S,S
M7H&,EJ=8LOPB L=]^<)G+!7X1VT3*X9' 9^0]/&SCV;PQ12C%@4FK$-,3USK
M%&N 3\ G!(FQP+"F*;2 UM9>9"8?BSA"G=+T5>+44J,B\W9;>Y]-M2>I'X39
MBX\7D[X,IY!#)B*KY2F2]$\E>#PL8>=S-;P)^(2Z2:'Z(,5HDR(3UT8"T%,
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M,MU^ENG60V@8!-[WKH]J.E816G\W!:V^>T5V^  RBMNEE]SFHDL1B
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MZ:S;]#>N$G-VK?1,L]0P;7YYRB2<ZP^?=:3XX\QE'>,S(%F(=J,&T2.CH4=
M.YV&$T,C\2N.V@-V3P@VRQK,425=]^5\N:X1-MNNFB7!#A>UNG;#T?0,_^P1
MX$H<^0_DBW6-;#%'C3,+QR%"*9%\#B&]-S6[3TH#E+;[Z_8FX>F3G9X$SS@+
M2W(@%+NM71]R=/&/\S5Q69 RU\)H[(,(%BXGX41QFQ\\'2)A?BK,>H8 Y'.;
MUW9]?6*68W0E@'R"A/2J7->F.OG\(!T?1F.HW^5]I'&Y9-,X% 9WI5$'Z A$
M;= (R7.HO23!B'X:J<=51#Z'8-0FZ=X2*:&V?J/$/9F0Y!.S;KWZSC"=-R):
MA^^%V;*8@E!I#74W??^\-:6>]NH\$04D71+B,S\'?53I7KH-AD0GYH' 9%C8
M448'G&R5=N;%G/,\$6N/!_A]ID=@Q['%' =FE7>O:2XLE1S]?"_57&C&C-$P
M'UT< DN_0'K>O*/?''=C!H8_#Z?7]3BL2.)6DH%GX)E$(PC9Z8ZXH/.6-H>4
M<[>7BA+T\GD!7M50C47_Y/,E-';(._IA25DYNWY* LBG2)E$Q%W5U$*5R:=P
M^+C$<TV(I/,MW!7H_"@[2T8T1BIJYY!^*(49*1&#X4,P4!4AGUA]2>K3X(V*
M>Y7)9WA86#8,U,F'V]!/7V$ZQC^"U$JS Q!=M/238 >$Y""#\_S:2G43LC:0
M-AQ\[K!V#YQH8=];>"^RS[Y$Q/AWXP@ZP#;\+^YT&S>:"Z<00=P@F8#^3RK3
M$^KLK8[^]'0O%4GFY;5&]?0VQD@/Y^1]$+D**>*)CG'/F[;V;QC>'+61+[S@
M1!XQ&B& D?P:+JZPG]D_^32>Q>#IB2J/DLDGUAM([6+RZ<]I28;CF:(V.Z0[
M MVED28+@S%:?3=C']1S><;UYE ,5%O_[ZCJGR(@G^N049(4?4%[?Z'D^K\)
M13ZS?0=/SEK:'2'M*6R*1Q"5C'+6.R)[<&AYM8X#%3S[G4CYK\0F$#-1W1X:
M0>RKK:XM$YYS=]1[QVG04.\]1N.X;70O]W/$4P5\P?I8369QOV3RB?3;!:@S
M#4>I-.Y)0G2;[ 81=!G<&+5!P0A(UM!XRC8N"RD=;5.GI>?;RX81M^<<LFY:
MZ9E>VM!XE/X[N*QDD&4FG\J1SV'4,<F:ZUJ-Y).,GZ.]M-6*:R5-1[^;],1G
MX^X'(-+V;6.NU\0HA"BNL:2K/&U2%9#/(=3@):'QD)A!3<1?\GY,&/*)DBPO
MA3D,1_0J>OX?H9]#7+*$O4,MJ7?&_=B] _3L;6'4/R/C F.:@NA*^A:_A)Z*
MRF9"@R*O3&I'?4 Z.X[Z=L;.T%R80P1Q0#(!W9#*])P1BG YVCE>/KS,=-OW
MX,UFX4@&O#J$C2$87H^CAD,UIX-H6.0:]*O';'I0,OY.%F%F\JD>^80>) /[
M;":?NP8,,)%:&D)SD;RM7QJ5,34>P"AVQ\7HMX;@@!LD?=HFN]PD /G<XC?Z
M@Q3!).B@;+'^<SX;#0T&L($F!/E$'6'.T7X2 O$<$NF9Q?2Q*C@PW%(SXU O
MFCL^1[2EGQ>6+0.[*& 4^2[4K$>Y5T(&2J)V=NT'CEJ]Q!%/U3#W^KTBJ/T<
MKFDJK$R=L:2BL'M'*?VI"-)MT27T!I[KF0P@^H":J\K'#F@W9/NFUJGZGB)E
MT!T+\=@HWL_5J&.3*;-,/I4DGW"4/:/:I:H:^72;TXGZJ<HB:41F4,>LZMV
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MI,39%;3*LZBGM9;V,)*^J6Q;CL[PPV;6=^DA,*31B/A)1B6Z%58T-^;"_18
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M(!1B(0@8-&,"@"-O&=/I&C^B:_T&&88 [_U#>A\71)G!E1)\.@WJ_>IIK(7
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9TH+Q_P\6^P?^2KX.&0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 17, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 17,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEOGENOMICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001077183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">74-2897368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9490 NeoGenomics Way,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort Myers,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(239)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">768-0600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock ($0.001 par value)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NEO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="neo-20260617.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://neogenomics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="neo-20260617.htm">neo-20260617.htm</File>
    <File>neo-20260617.xsd</File>
    <File>neo-20260617_lab.xml</File>
    <File>neo-20260617_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "neo-20260617.htm": {
   "nsprefix": "neo",
   "nsuri": "http://neogenomics.com/20260617",
   "dts": {
    "inline": {
     "local": [
      "neo-20260617.htm"
     ]
    },
    "schema": {
     "local": [
      "neo-20260617.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "neo-20260617_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "neo-20260617_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://neogenomics.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "neo-20260617.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "neo-20260617.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001077183-26-000031-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001077183-26-000031-xbrl.zip
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M9A+2)U12/%?M-4W:_!5:PPS\ S%B^W6#@H\5NL=-B5P&&4.':%1]1[DSDTG
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MS"Q<M2N" Z,?_$:\"EEW>.9ZPY9J @D[3:2+0:;,S#> 1@C>\2DQ-I-6-D"
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MVUZ8L#I/8<KZ+ 4+PL02N:"\&D*I'*!$E/P:$J1Q6A%\.(I0[NJ[08H8SXI
M'XL0Y*.FNY^CF%(D6:H^*75L%%0KU)'J\GNF^%I^XB%^[G.6$H426[J^6YU?
MYOG]\.5F^=4\]!%P)PG+3[ (4OD>#&83Z=&,NH9*]?#9%,UPQ=#R2?FYG*0Z
M1W?)I"E7JC/Z6 6MS547N<,?LY?_0>[=OU.H^Y#'VH"A46\XM9$\ON.A'#1,
MP_A;18UKGH@1!7WHI2BQ_/<<R (H-*P:()W20#9$-AS2='(,/VY@"IF,&@Z
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M"_'J],/F.^GJC\B>?O@?4$L#!!0    ( *I0T5S-7DR, @8  /4R   4
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M4XPI-@1'R/9*^Z9BM]0'7,_L9>&.T__9I55E\FFQ6%SG#\OGLC7E43$0 D,
M#4$":K]$BF4O!K;*=@,AX+IE?S-W3,-ED:4JK=)\]MY/<%PJLLWH$21^1:0E
M4 I2B&,D5,_AH*W9C8. RY4];=PQ!.?.U 0;/[%M=F_4&W_<1VO; YM0T/>"
M,, XI GBROJQK1<,SVMW@R+@6N5 MH8%QVE97AOW0E\8],\^@_V+@ A#C:A
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M<G1I8FQE;F]T92YH=&U02P$"% ,4    " "J4-%<F4 -"KX/   I<P  $
M            @ &6%   ;F5O+3(P,C8P-C$W+FAT;5!+ 0(4 Q0    ( *I0
MT5SA#S:M8@(  /,&   0              "  8(D  !N96\M,C R-C V,3<N
M>'-D4$L! A0#%     @ JE#17+78\<M\"0  %%@  !0              ( !
M$B<  &YE;RTR,#(V,#8Q-U]L86(N>&UL4$L! A0#%     @ JE#17,U>3(P"
M!@  ]3(  !0              ( !P#   &YE;RTR,#(V,#8Q-U]P<F4N>&UL
64$L%!@     %  4 3 $  /0V      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>neo-20260617_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="neo-20260617.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001077183</identifier>
        </entity>
        <period>
            <startDate>2026-06-17</startDate>
            <endDate>2026-06-17</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001077183</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2026-06-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">NEOGENOMICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-35756</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">74-2897368</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">9490 NeoGenomics Way,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Fort Myers,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">33912</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">(239)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">768-0600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common stock ($0.001 par value)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">NEO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
